News for Rezolute, Inc. (RZLT)

California-based GigaCloud Technology Inc. (GCT) is down over 21 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

On February 18, 2025, Wladimir Hogenhuis, a Director at Rezolute Inc, purchased 10,000 shares of the company, as reported in a SEC Filing. Following this transa

Rezolute advances therapies for hypoglycemia with RZ358 and RZ402, showing efficacy in trials. Read why RZLT stock is a compelling, albeit cautious, investment.

Significant Transaction on December 31, 2024 On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a noteworthy transaction by ac

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and Orphan Drug Designa

**media[529004]**

If you are looking for stocks that are well positioned to maintain their recent uptrend, Rezolute (RZLT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. ( SEPN), a clinical-stage biotech company pioneering a new era of G protein-coup

On December 10, 2024, Velan Capital Investment Management LP (Trades, Portfolio) executed a significant transaction involving Protara Therapeutics Inc (TARA). T

REDWOOD CITY, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. ( RZLT) (”œRezolute” or the ”œCompany”), a late-stage biopharmaceutical company d

Rezolute is advancing treatments for Congenital Hyperinsulinism and Diabetic Macular Edema with RZ402. Learn why RZLT stock could see growth.

Phase 3 registrational trial for ersodetug in patients with tumor hyperinsulinism (HI) expected to commence in 2025; real-world patient benefit demonstrated in

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a look at where Rezolute, Inc.

**media[459670]**

Maryland-based biotechnology company Gain Therapeutics, Inc. (GANX) is down over 27 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Every investor aspires to see the stocks in their portfolio deliver substantial returns. Though trading is a game of probabilities, with both wins and losses, some investors manage to hit the jackpot.

Earned $9 million milestone upon U.S. Food and Drug Administration’s approval of Day One’s OJEMDA™ (tovorafenib); XOMA is entitled to receive a mid-single...

The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.